ORTHOPEUTICS, L.P.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 14241
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 2138
 
 
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 269
 
 
 
C07K PEPTIDES 2134
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
 
 
F23R GENERATING COMBUSTION PRODUCTS OF HIGH PRESSURE OR HIGH VELOCITY, e.g. GAS-TURBINE COMBUSTION CHAMBERS 128

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0354,637 FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEAJun 13, 16Dec 14, 17[A61K]
2016/0116,169 MIXER RETENTIONSep 29, 15Apr 28, 16[F23R]
2016/0015,555 TISSUE CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEASep 29, 15Jan 21, 16[A61F, A61M]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918870 Tissue crosslinking for treatment of snoring and obstructive sleep apneaSep 29, 15Mar 20, 18[A61K, A61F, A61M]
9492592 Crosslinker enhanced repair of knee meniscusApr 13, 15Nov 15, 16[A61F, A61L]
9192507 Tissue crosslinking for treatment of snoring and obstructive sleep apneaJun 28, 11Nov 24, 15[A61K, A61F]
9101602 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissuesDec 13, 10Aug 11, 15[A61K]
9084772 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissuesAug 29, 02Jul 21, 15[A61K, C07K]
8450276 Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeabilityJun 16, 10May 28, 13[A61K, A61L]
8283322 Formulations for nonsurgical exogenous crosslink therapyJul 01, 09Oct 09, 12[A61K, C08G, C07K]
8211938 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformityMar 02, 10Jul 03, 12[A61K, C07D]
8198248 Formulations for nonsurgical exogenous crosslink therapySep 03, 08Jun 12, 12[A61K]
8153600 Direct application of non-toxic crosslinking reagents to resist progressive spinal deformityFeb 02, 06Apr 10, 12[A61K, C07H]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0085,569 CROSSLINKER ENHANCED REPAIR OF KNEE MENISCUSAbandonedMay 26, 11Apr 04, 13[A61F]
2010/0040,593 FORMULATIONS FOR NONSURGICAL EXOGENOUS CROSSLINK THERAPYAbandonedAug 15, 08Feb 18, 10[A61K, A61P]
2007/0202,143 Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral jointsAbandonedMar 22, 07Aug 30, 07[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.